Tech Company Financing Transactions
Aclid Funding Round
On 10/12/2023, Aclid raised $3.3 million in Seed funding from 2048 Ventures and IA Ventures.
Transaction Overview
Company Name
Announced On
10/12/2023
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Seed
Investors
2048 Ventures (Lead Investor)
IA Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to meet customer demand for its real-time screening and verification platform.
Company Information
Company Status
Private & Independent
Industry
Security
Mailing Address
442 5th Avenue Manhattan 2300
New York, NY 10018
USA
New York, NY 10018
USA
Phone
Undisclosed
Website
Email Address
Overview
Aclid was founded in 2021, in the wake of a pandemic and record-breaking growth of synthetic biology. Biological security was becoming essential, but we knew how hard it could be to build a strong security foundation. Aclid was inspired by a vision to make genetic engineering safer and more accessible.
Management Team
Browse more venture capital transactions:
Prev: 10/12/2023: Beam Global venture capital transaction
Next: 10/12/2023: Scope3 venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs